These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9671005)

  • 21. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stents versus coronary-artery bypass grafting for left main coronary artery disease.
    Seung KB; Park DW; Kim YH; Lee SW; Lee CW; Hong MK; Park SW; Yun SC; Gwon HC; Jeong MH; Jang Y; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    N Engl J Med; 2008 Apr; 358(17):1781-92. PubMed ID: 18378517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stenting of unprotected left main coronary artery: complications during 3 years follow up].
    Batyraliev TA; Fettser DV; Karben ZA; Sidorenko BA
    Kardiologiia; 2009; 49(2):22-6. PubMed ID: 19254212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound predictors of target lesion revascularization after stenting of protected left main coronary artery stenoses.
    Hong MK; Mintz GS; Hong MK; Pichard AD; Satler LF; Kent KM; Popma JJ; Leon MB
    Am J Cardiol; 1999 Jan; 83(2):175-9. PubMed ID: 10073817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
    Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
    J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left main coronary stenting in a non surgical octogenarian population: a possible approach.
    Dahdouh Z; Roule V; Sabatier R; Lognoné T; Manrique A; Bignon M; Malcor G; Massetti M; Grollier G
    Cardiovasc Revasc Med; 2012; 13(2):119-24. PubMed ID: 22406303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent.
    Bhargava B; Waksman R; Lansky AJ; Kornowski R; Mehran R; Leon MB
    Catheter Cardiovasc Interv; 2001 Nov; 54(3):295-300. PubMed ID: 11747152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The immediate and long-term prognosis following unprotected left main coronary artery stenting in Chinese--Chinese Registry of Unprotected Left Main Coronary Artery Stenting (CHANCE Study)].
    CHANCE Study Group
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):210-5. PubMed ID: 15929812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
    Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
    N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
    Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
    Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
    Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    J Am Coll Cardiol; 2011 Mar; 57(12):1349-58. PubMed ID: 21414531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease.
    Higami H; Shiomi H; Niki S; Tazaki J; Imai M; Saito N; Makiyama T; Shizuta S; Shioi T; Ono K; Kimura T
    Cardiovasc Interv Ther; 2015 Jul; 30(3):189-97. PubMed ID: 25194953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection.
    Black A; Cortina R; Bossi I; Choussat R; Fajadet J; Marco J
    J Am Coll Cardiol; 2001 Mar; 37(3):832-8. PubMed ID: 11693759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery.
    Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of elective stenting in unprotected left main coronary disease.
    Wong P; Wong V; Tse KK; Chan W; Ko P; Wong CM; Leung AW; Fong PC; Cheng CH; Tai YT; Leung WH; Liu ML
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):153-9. PubMed ID: 10348534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.